(Q78061400)
Statements
A phase II trial of irinotecan in hormone-refractory prostate cancer (English)
D M Reese
S Tchekmedyian
Y Chapman
D Prager
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference